Michael Bergqvist

Kontakt

michael.bergqvist@akademiska.se

090-786 50 77

Verksam som

Adjungerad professor vid Institutionen för diagnostik och intervention Enhet: Onkologi

Sjukhuset i Gävle Umeå universitet, 901 85 Umeå

Publikationer Publikationer

Regional perspectives on complementary and alternative medicine: results of a regional survey

Complementary Medicine Research, S. Karger 2024, Vol. 31, (6) : 497-505

Källman, Mikael; Bergström, Stefan; Holgersson, Georg; et al.

Use of CAM among cancer patients: results of a regional survey in Sweden

BMC Complementary Medicine and Therapies, BioMed Central (BMC) 2023, Vol. 23, (1)

Källman, Mikael; Bergström, Stefan; Carlsson, Tobias; et al.

Reply to Assoc. Prof. Kocak

Acta Oncologica, Taylor & Francis Group 2022, Vol. 61, (3) : 320-320

Willén, Linda; Berglund, Anders; Bergström, Stefan; et al.

Are older patients with non-small cell lung cancer receiving optimal care? A population-based study

Acta Oncologica, Taylor & Francis 2022, Vol. 61, (3) : 309-317

Willén, Linda; Berglund, Anders; Bergström, Stefan; et al.

Patterns of care and outcomes in immigrants with non-small cell lung cancer: a population-based study (Sweden)

PLOS ONE, Public Library of Science 2022, Vol. 17, (12)

Willén, Linda; Berglund, Anders; Bergström, Stefan; et al.

Radiotherapy as elective treatment of the node-negative neck in oral squamous cell cancer

Anticancer Research, Vol. 41, (7) : 3489-3498

Lundin, Erik; Reizenstein, Johan; Landstrom, Fredrik; et al.

Real world utilization of EGFR TKIs and prognostic factors for survival in NSCLC during 2010-2016 in Sweden: A nationwide observational study

International Journal of Cancer, John Wiley & Sons 2020, Vol. 146, (9) : 2510-2517

Bergqvist, Michael; Christensen, Helene N.; Wiklund, Fredrik; et al.

No Evidence for Increased Brain Tumour Incidence in the Swedish National Cancer Register Between Years 1980-2012

Anticancer Research, International Institute of Anticancer Research 2019, Vol. 39, (2) : 791-796

Nilsson, Jonas; Järås, Jacob; Henriksson, Roger; et al.

Educational level and management and outcomes in non-small cell lung cancer. A nationwide population-based study

Lung Cancer, Elsevier 2019, Vol. 131 : 40-46

Willén, Linda; Berglund, Anders; Bergström, Stefan; et al.

Små och minskande skillnader i lungcancervården

Läkartidningen

Willén, Linda; Isaksson, Johan; Bergström, Stefan; et al.

Characteristics and Long-Term OS of Non-Small Cell Lung Cancer Patients Receiving EGFR Tyrosine Kinase Inhibitor Treatment

Journal of Thoracic Oncology, Elsevier 2018, Vol. 13, (10) : S419-S419

Bergqvist, Michael; Christensen, H. Nordahl; Wiklund, F.; et al.

EGFR tyrosine kinase inhibitors in non-small cell lung cancer: Nationwide register-based cohort study in Sweden

Annals of Oncology, Oxford University Press 2018, Vol. 29 : 526-526

Bergström, S.; Christensen, H. Nordahl; Wiklund, F.; et al.

CD93 promotes beta(1) integrin activation and fibronectin fibrillogenesis during tumor angiogenesis

Journal of Clinical Investigation, AMER SOC CLINICAL INVESTIGATION INC 2018, Vol. 128, (8) : 3280-3297

Lugano, Roberta; Vemuri, Kalyani; Yu, Di; et al.

The role of income in brain tumor patients: a descriptive register-based study

Medical Oncology, Humana Press 2018, Vol. 35, (4)

Nilsson, Jonas; Holgersson, Georg; Järås, Jacob; et al.

Phase II randomized study of the IGF-1R pathway modulator AXL1717 compared to docetaxel in patients with previously treated, locally advanced or metastatic non-small cell lung cancer

Acta Oncologica, Vol. 56, (3) : 441-447

Bergqvist, Michael; Holgersson, Georg; Bondarenko, Igor; et al.

Affinity Proteomics Exploration of Melanoma Identifies Proteins in Serum with Associations to T-Stage and Recurrence

Translational Oncology, Vol. 10, (3) : 385-395

Bystrom, Sanna; Fredolini, Claudia; Edqvist, Per-Henrik; et al.

The prognostic value of pre-treatment leukocytosis in patients with previously treated, stage IIIB/IV non-small cell lung cancer treated with the IGF-1R pathway modulator AXL1717 or docetaxel: a retrospective analysis of a phase II trial

Asian Pacific Journal of Cancer Prevention, Vol. 18, (6) : 1555-1560

Holgersson, Georg; Bergqvist, Michael; Nilsson, R. Jonas A.; et al.

The prognostic value of pre-treatment thrombocytosis in two cohorts of patients with non-small cell lung cancer treated with curatively intended chemoradiotherapy

Neoplasma (Bratislava), Bratislava: AEPress 2017, Vol. 64, (6) : 909-915

Holgersson, Georg; Bergström, Stefan; Hallqvist, Anders; et al.

End-of-life care: Where do cancer patients want to die? A systematic review

Asia-Pacific Journal of Clinical Oncology, John Wiley & Sons 2017, Vol. 13, (6) : 356-364

Nilsson, Jonas; Blomberg, Carl; Holgersson, Georg; et al.

Serglycin as a potential biomarker for glioma: association of serglycin expression, extent of mast cell recruitment and glioblastoma progression

Oncotarget, Vol. 8, (15) : 24815-24827

Roy, Ananya; Attarha, Sanaz; Weishaupt, Holger; et al.

A novel oral insulin-like growth factor-1 receptor pathway modulator and its implications for patients with non-small cell lung carcinoma: A phase I clinical trial

Acta Oncologica, Vol. 55, (2) : 140-148

Ekman, Simon; Harmenberg, Johan; Frödin, Jan-Erik; et al.

Brain tumors in Sweden: Data from a population-based registry 1999-2012

Acta Oncologica, Vol. 54, (3) : 377-384

Asklund, Thomas; Malmström, Annika; Bergqvist, Michael; et al.

A phase I pilot study of the insulin-like growth factor 1 receptor pathway modulator AXL1717 in combination with gemcitabine HCl and carboplatin in previously untreated, locally advanced, or metastatic non-small cell lung cancer

Medical Oncology, Vol. 32, (4)

Holgersson, Georg; Bergström, Stefan; Harmenberg, Johan; et al.

Effect of Increased Radiotoxicity on Survival of Patients with Non-small Cell Lung Cancer Treated with Curatively Intended Radiotherapy

Anticancer Research, Vol. 35, (10) : 5491-5497

Holgersson, Georg; Bergström, Stefan; Liv, Per; et al.

FGF2 as a potential prognostic biomarker for proneural glioma patients

Acta Oncologica, Informa Healthcare 2015, Vol. 54, (3) : 385-394

Sooman, Linda; Freyhult, Eva; Jaiswal, Archita; et al.

Human Cytomegalovirus Tegument Protein pp65 Is Detected in All Intra- and Extra-Axial Brain Tumours Independent of the Tumour Type or Grade

PLOS ONE, Vol. 9, (9) : e108861-

Libard, Sylwia; Popova, Svetlana N.; Amini, Rose-Marie; et al.

The impact of hyperfractionated radiotherapy regimen in patients with non-small cell lung cancer

Medical Oncology, Humana Press 2013, Vol. 30, (1)

Holgersson, Georg; Bergqvist, Michael; Nyman, Jan; et al.

Depression, anxiety, intoxication and suicide following a diagnosis of non-small cell lung cancer: A population-based study (Sweden)

Willén, Linda; Berglund, Anders; Bergström, Stefan; et al.

Visa publikationer i DiVA